Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) CEO Vininder Singh sold 27,958 shares of Bullfrog AI stock in a transaction dated Thursday, April 3rd. The stock was sold at an average price of $1.44, for a total value of $40,259.52. Following the completion of the transaction, the chief executive officer now directly owns 2,348,341 shares in the company, valued at $3,381,611.04. This represents a 1.18 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.
Vininder Singh also recently made the following trade(s):
- On Tuesday, April 1st, Vininder Singh sold 7,245 shares of Bullfrog AI stock. The stock was sold at an average price of $1.61, for a total transaction of $11,664.45.
Bullfrog AI Price Performance
BFRG stock opened at $1.30 on Friday. The firm has a market capitalization of $12.24 million, a P/E ratio of -1.53 and a beta of 0.33. Bullfrog AI Holdings, Inc. has a 52-week low of $1.23 and a 52-week high of $4.84. The company’s 50 day simple moving average is $2.28 and its 200-day simple moving average is $2.34.
Institutional Investors Weigh In On Bullfrog AI
Several hedge funds have recently bought and sold shares of BFRG. Two Sigma Securities LLC acquired a new position in shares of Bullfrog AI in the 4th quarter valued at about $41,000. Raymond James Financial Inc. purchased a new stake in shares of Bullfrog AI during the fourth quarter worth $30,000. Finally, Geode Capital Management LLC boosted its position in Bullfrog AI by 31.0% during the fourth quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock valued at $94,000 after purchasing an additional 11,140 shares during the last quarter. 0.96% of the stock is owned by hedge funds and other institutional investors.
About Bullfrog AI
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
Featured Stories
- Five stocks we like better than Bullfrog AI
- Short Selling – The Pros and Cons
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Spotify Stock Eyes Double-Digit UpsideāIs Now the Time to Buy?
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.